Successful renewal of the GMP Certificate for CF Pharma Ltd.

Three members from the National Institute of Pharmacy (Hungarian: Országos Gyógyszerészeti Intézet, known as: „OGYI”) audited our companies for GMP compliance on 5 APIs (Atracurium besylate, Cabergoline, Cisatracurium besylate, Biperiden HLC.)

Our company successfully received the certificates on 2023 February 27.

Your Choices Regarding Cookies on this Site

Some functionality on this site requires your consent for cookies to work properly.

We use cookies to enhance your visit. By clicking Agree and Proceed you accept our use of cookies. You can also click on More Information to see detailed descriptions of the types of cookies and choose whether to accept certain cookies while on the site.